Given the critical roles of CEP192 in the cell cycle, it is worth further exploring the impacts of CEP192 silencing on senescence and SASP factors, which may provide evidence for CEP192 as a therapeutic target to remodel the tumor microenvironment in HCC tissues. This evidence concerns the gene CEP192 and hepatocellular carcinoma.